Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Oxycodone

Chemical compound

Oxycodone    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Oxycodone: Chemical compound
Oxycodone, sold under brand name OxyContin among others, is an opioid medication used for treatment of moderate to severe pain. It is usually taken by mouth, and is available in immediate release and controlled release formulations. Onset of pain relief typically begins within 15 minutes and lasts for up to six hours with the immediate release formulation. In the United Kingdom, it is available by injection. Combination products are also available with paracetamol (acetaminophen) or aspirin.

0
shares
ShareTweetSavePostSend
 

Purdue Pharma seeks to halt opioid suits against company, Sacklers

OxyContin maker Purdue Pharma LP on Wednesday asked a U.S. bankruptcy judge to halt for roughly nine months more than 2,600 lawsuits alleging the company and its controlling Sackler family helped fuel..
Reuters - Published

Oxycontin maker Purdue begins bankruptcy in push to settle opioid lawsuits

OxyContin maker Purdue Pharma LP is expected in court on Tuesday to lay out its plan for using bankruptcy to resolve more than 2,600 lawsuits alleging the company fueled the U.S. opioid crisis.
Reuters - Published

Videos for Oxycodone

OxyContin maker files for bankruptcy [Video]OxyContin maker files for bankruptcy

Purdue Pharma, the company behind OxyContin, filed for bankruptcy protection Sunday night (September 15), amid more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic...

Credit: Reuters Studio     Duration: 01:24Published

Purdue reaches tentative opioid settlement -sources [Video]Purdue reaches tentative opioid settlement -sources

OxyContin maker Purdue Pharma reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states..

Credit: Reuters Studio     Duration: 00:45Published

J&J ordered to pay $572 mln in Oklahoma opioid case [Video]J&J ordered to pay $572 mln in Oklahoma opioid case

An Oklahoma judge on Monday found Johnson & Johnson liable for fueling an opioid epidemic in the state by deceptively marketing painkillers, and ordered the drugmaker to pay damages of $572 million...

Credit: Reuters Studio     Duration: 01:19Published

Oklahoma AG tells J&J CEO to Oklahoma AG tells J&J CEO to "get out his checkbook"

Oklahoma Attorney General Mike Hunter slammed Johnson & Johnson as the "kingpin behind the nation's ongoing opioid crisis" moments after a judge ruled against the drugmaker and ordered it to pay $572..

Credit: Reuters Studio     Duration: 01:04Published

 

What's next for OxyContin maker Purdue Pharma

OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped fuel the U.S. opioid crisis.
Reuters - Published

OxyContin maker Purdue Pharma files for bankruptcy amid opioid crisis

OxyContin maker Purdue Pharma LP filed for bankruptcy protection Sunday night, succumbing to pressure from more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic.
France 24 - Published Also reported by •USATODAY.comReutersCBS News

AP Top Stories September 16

Here's the latest for Monday September 16th: 49,000 UAW members strike against GM; Oil prices spike after attack in Saudi Arabia; Oxycontin maker Purdue Pharma files for bankruptcy; more.  
USATODAY.com - Published

NY finds $1B in hidden transfers by family behind OxyContin

ny finds $1b in hidden transfers by family behind oxycontin
NEW YORK (AP) — The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York’s attorney general contends in court papers..
WorldNews - Published

Eye Opener: The Trump administration moves to ban most flavored e-cigarettes

President Trump proposes a ban on most flavored vaping products. Also, 23 states have reached a tentative settlement with OxyContin maker Purdue Pharma over the nation’s opioid crisis. All that and..
CBS News - Published

Purdue Pharma reaches tentative opioid settlement with some: sources

OxyContin maker Purdue Pharma LP reached a tentative agreement with some plaintiffs to resolve litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states..
Reuters - Published

Purdue OxyContin settlement would rank among largest in pharma history

OxyContin maker Purdue Pharma LP has reached a tentative multibillion-dollar agreement with some plaintiffs aimed at settling thousands of lawsuits over its alleged role in the U.S. opioid crisis,..
Reuters - Published

Exclusive: Purdue Pharma nears partial opioid settlement, bankruptcy filing - sources

OxyContin maker Purdue Pharma LP is nearing a partial agreement to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its..
Reuters - Published

Exclusive: OxyContin maker prepares 'free-fall' bankruptcy as settlement talks stall

OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a settlement with U.S. communities over widespread opioid litigation, three..
Reuters - Published

US firm Purdue Pharma 'offers up to $12 billion' to settle opioid lawsuits

OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar..
France 24 - Published Also reported by •BBC NewsReuters

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar..
Reuters - Published

OxyContin maker Purdue Pharma reportedly offering opioid settlement up to $12B

OxyContin maker Purdue Pharma is reportedly offering a settlement worth up to $12 billion to resolve claims over its role in the opioid crisis.
USATODAY.com - Published

US lawmakers demand UN health agency change opioid guidance

us lawmakers demand un health agency change opioid guidance
Two U.S. lawmakers are calling on the World Health Organization to withdraw pain care guidelines that include what they say are false claims about the safety of prescription opioids. They say the..
WorldNews - Published

The Met Will Turn Down Sackler Money Amid Fury Over the Opioid Crisis

The decision by one of the world’s leading museums could spur other institutions to turn down philanthropy from the family behind OxyContin.
NYTimes.com - Published

Purdue's Sackler family fights 'inflammatory' Massachusetts opioid case

Members of the Sackler family behind OxyContin maker Purdue Pharma LP have asked a judge to toss a lawsuit by Massachusetts' attorney general claiming they helped fuel the U.S. opioid epidemic, arguing..
Reuters - Published

NY opioid lawsuit hits billionaire family behind OxyContin

ny opioid lawsuit hits billionaire family behind oxycontin
New York on Thursday sued the billionaire family behind OxyContin, joining a growing list of state and local governments alleging the drugmaker sparked the nation’s opioid crisis by putting hunger..
WorldNews - Published

Purdue Pharma agrees to $270 million settlement in Oklahoma opioid case

OxyContin maker Purdue Pharma LP and members of the wealthy Sackler family that own the company reached a $270 million settlement to resolve a lawsuit brought by the state of Oklahoma accusing the..
Reuters - Published

OxyContin maker Purdue agrees to settle Oklahoma opioid case: source

Purdue Pharma LP has agreed to settle a lawsuit by the state of Oklahoma accusing the OxyContin painkiller maker of helping fuel an opioid abuse epidemic, a person familiar with the matter said.
Reuters - Published

Oklahoma top court clears way for Purdue, J&J, Teva to face opioid trial

Oklahoma's top court on Monday declined to delay a landmark trial set for May in a multibillion-dollar lawsuit accusing OxyContin maker Purdue Pharma LP and two other drugmakers of helping fuel an..
Reuters - Published

Opioid crisis pressure prompts Sackler Trust to halt U.K. donations

The major U.K.-based charitable trust is funded by the same family behind OxyContin maker Purdue Pharma, which is facing multiple U.S. lawsuits
CBS News - Published

OxyContin Manufacturer Exploring Bankruptcy Amid Continued Opioid Epidemic

oxycontin manufacturer exploring bankruptcy amid continued opioid epidemic
Purdue Pharma LP, the maker of the powerful opioid OxyContin, is exploring filing or bankruptcy to address potential liabilities from nearly 2,000 lawsuits against the pharmaceutical company on Monday,..
WorldNews - Published

You Might Like


Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.